PegIntron Interactions
There are 227 drugs known to interact with PegIntron (peginterferon alfa-2b), along with 20 disease interactions. Of the total drug interactions, 41 are major, 182 are moderate, and 4 are minor.
- View all 227 medications that may interact with PegIntron
- View PegIntron disease interactions (20)
Most frequently checked interactions
View interaction reports for PegIntron (peginterferon alfa-2b) and the medicines listed below.
- acyclovir
- adefovir
- amitriptyline
- amoxicillin / clavulanate
- Aptivus (tipranavir)
- Benadryl (diphenhydramine)
- boceprevir
- clarithromycin
- Coumadin (warfarin)
- entecavir
- folic acid
- gabapentin
- ganciclovir
- Haldol Decanoate (haloperidol)
- hydroxyzine
- ibuprofen
- Implanon (etonogestrel)
- Incivek (telaprevir)
- interferon alfa-2a
- isoniazid
- Janumet (metformin / sitagliptin)
- Januvia (sitagliptin)
- Klonopin (clonazepam)
- lamivudine
- ledipasvir / sofosbuvir
- Levemir (insulin detemir)
- Pegasys (peginterferon alfa-2a)
- Ribasphere (ribavirin)
- ribavirin
- Victrelis (boceprevir)
PegIntron disease interactions
There are 20 disease interactions with PegIntron (peginterferon alfa-2b) which include:
- renal dysfunction
- autoimmune diseases
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- autoimmune hepatitis
- depression
- severe hepatic disease
- hemoglobinopathies
- renal dysfunction
- colitis
- diabetes mellitus
- myelosuppression
- peripheral neuropathy
- bone marrow suppression
- endocrine disorders
- ophthalmological disorders
- pancreatitis
- pulmonary disorders
Report options
More about PegIntron (peginterferon alfa-2b)
- PegIntron consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic interferons
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Vemlidy
Vemlidy (tenofovir alafenamide) is an oral, once-daily, antiviral tablet that may be used to treat ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Mavyret
Mavyret (glecaprevir/pibrentasvir) is an oral combination medicine containing fixed doses of two ...
Lamivudine
Lamivudine systemic is used for hepatitis b, HIV Infection, nonoccupational exposure, occupational ...
Sofosbuvir/velpatasvir
Sofosbuvir-velpatasvir (brand name Epclusa) is used to treat chronic hepatitis C (HCV) genotypes 1 ...
Tenofovir disoproxil
Tenofovir disoproxil systemic is used for hepatitis b, HIV Infection, nonoccupational exposure ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.